Mitotic index, microvascular proliferation, and necrosis define 3 groups of 1p/19q codeleted anaplastic oligodendrogliomas associated with different genomic alterations

Neuro-Oncology

Volumn 16, Issue 9, 2014, Pages 1244-1254

  Figarella Branger, Dominique ^a,b   Mokhtari, Karima ^c,d,e   Dehais, Caroline ^c   Jouvet, Anne ^f   Uro Coste, Emmanuelle ^g,h   Colin, Carole ^b   Carpentier, Catherine ^d,e   Forest, Fabien ⁱ   Maurage, Claude Alain ^j   Vignaud, Jean Michel ^k   Polivka, Marc ^i,l   Lechapt Zalcman, Emmanuelle ^m,n   Eimer, Sandrine ^o,p   Viennet, Gabriel ^q   Quintin Roué, Isabelle ^r   Aubriot Lorton, Marie Hélène ^s   Diebold, Marie Danièle ^t   Loussouarn, Delphine ^u   Lacroix, Catherine ^v   Rigau, Valérie ^w   Laquerrière, Annie ^x   Vandenbos, Fanny ^y   Michalak, Sophie ^z   Sevestre, Henri ^aa   Peoch, Michel ^i,l   Labrousse, François ^ab   Christov, Christo ^ac   Kemeny, Jean Louis ^ad   Chenard, Marie Pierre ^ae   Chiforeanu, Danchristian ^af   Ducray, François ^ag,ah   Idbaih, Ahmed ^c,d,e   Desenclos, Christine ^ai   Menei, Philippe ^ai   Al Nader, Edmond ^ai   Godard, Joel ^ai   Servagi Vernat, Stéphanie ^ai   Carpentier, Antoine ^ai   Loiseau, Hugues ^ai   Dam Hieu, Phong ^ai   Guillamo, Jean Sebastien ^ai   Emery, Evelyne ^ai   Verelle, Pierre ^ai   Durando, Xavier ^ai   Faillot, Thierry ^ai   Le Guerinel, Caroline ^ai   Ghiringhelli, François ^ai   Parker, Fabrice ^ai   Adam, Clovis ^ai   Dubois, François ^ai   Ramirez, Carole ^ai   Gueye, Edouard Marcel ^ai   Honnorat, Jerome ^ai   Chinot, Olivier ^ai   Bauchet, Luc ^ai   Beauchesne, Patrick ^ai   Campone, Mario ^ai   Frenel, Jean Sébastien ^ai   Fontaine, Denys ^ai   Campello, Chantal ^ai   Roger, Pascal ^ai   Heitzmann, Anne ^ai   Fesneau, Mélanie ^ai   Delattre, Jean Yves ^ai   Elouadhani Hamdi, Selma ^ai   Ricard, Damien ^ai   Colin, Philippe ^ai   Vauléon, Elodie ^ai   Langlois, Olivier ^ai   Fotso, Marie Janette Motsuo ^ai   Andraud, Marie ^ai   Mouton, Servane ^ai   Noel, Georges ^ai   Desse, Nicolas ^ai   Soulard, Raoulin ^ai   Cohen Moyal, Elisabeth ^ai   Lubrano, Vincent ^ai   Dhermain, Frederic ^ai   more..

^a TIMONE HOSPITAL   (France)

^b University of the Mediterranean Aix Marseille II   (France)

^c PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

^d SORBONNE UNIVERSITÉ   (France)

^e INSERM   (France)

^f Centre de Biologie et de Pathologie Est   (France)

^g TOULOUSE UNIVERSITY HOSPITAL   (France)

^h UNIVERSITÉ DE TOULOUSE   (France)

ⁱ HÔPITAL NORD   (France)

^j LILLE UNIVERSITY HOSPITAL   (France)

^k UNIVERSITY HOSPITAL OF NANCY   (France)

^l HÔPITAL LARIBOISIÈRE   (France)

^m CHU CÔTE DE NACRE   (France)

ⁿ GIP CYCERON   (France)

^o HÔPITAL PELLEGRIN   (France)

^p Bordeaux Institute of Oncology   (France)

^q UNIVERSITY HOSPITAL JEAN MINJOZ   (France)

^r SERVICE DE RHUMATOLOGIE   (France)

^s DIJON UNIVERSITY HOSPITAL   (France)

^t SERVICE DE DERMATOLOGIE   (France)

^u CHU de Nantes   (France)

^v BICÊTRE HOSPITAL   (France)

^w GUI DE CHAULIAC HOSPITAL   (France)

^x HÔPITAL CHARLES NICOLLE   (France)

^y PASTEUR HOSPITAL   (France)

^z ANGERS UNIVERSITY HOSPITAL   (France)

^aa AMIENS UNIVERSITY HOSPITAL   (France)

^ab DUPUYTREN UNIVERSITY HOSPITAL   (France)

^ac HENRI MONDOR HOSPITAL   (France)

^ad SERVICE DE RHUMATOLOGIE   (France)

^ae HÔPITAL DE HAUTEPIERRE   (France)

^af PONTCHAILLOU UNIVERSITY HOSPITAL   (France)

^ag HÔPITAL NEUROLOGIQUE   (France)

^ah LYON NEUROSCIENCE RESEARCH CENTER   (France)

^ai INSERM U1028 CNRS UMR5292 ^*

more..

Author keywords

1p 19q codeletion; Anaplastic oligodendrogliomas; Microvascular proliferation; Mitoses; Necrosis

Indexed keywords

ALPHA INTERNEXIN; ISOCITRATE DEHYDROGENASE; KI 67 ANTIGEN; TEMOZOLOMIDE; IDH1 PROTEIN, HUMAN; ISOCITRATE DEHYDROGENASE 2, HUMAN;

ADULT; ARTICLE; CANCER ADJUVANT THERAPY; CANCER RADIOTHERAPY; CANCER SURVIVAL; CARDIOVASCULAR PARAMETERS; CHROMOSOMAL INSTABILITY; CHROMOSOME 19Q; CHROMOSOME 1P; CHROMOSOME 4; CHROMOSOME DELETION; CHROMOSOME LOSS; CLINICAL FEATURE; CONTROLLED STUDY; FEMALE; FOLLOW UP; GENE MUTATION; GENETIC ASSOCIATION; GENOMICS; HISTOPATHOLOGY; HUMAN; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MALE; MICROVASCULAR PROLIFERATION; MITOSIS INDEX; MULTIMODALITY CANCER THERAPY; NECROSIS; OLIGODENDROGLIOMA; OVERALL SURVIVAL; PROGRESSION FREE SURVIVAL; PROTEIN EXPRESSION; BRAIN; BRAIN TUMOR; CHROMOSOME 1; CHROMOSOME 19; COMPLICATION; DISEASE FREE SURVIVAL; GENETICS; NEOVASCULARIZATION (PATHOLOGY); PATHOLOGY; VASCULARIZATION;

BRAIN; BRAIN NEOPLASMS; CHROMOSOME DELETION; CHROMOSOMES, HUMAN, PAIR 1; CHROMOSOMES, HUMAN, PAIR 19; DISEASE-FREE SURVIVAL; HUMANS; ISOCITRATE DEHYDROGENASE; MITOTIC INDEX; NECROSIS; NEOVASCULARIZATION, PATHOLOGIC; OLIGODENDROGLIOMA;

EID: 84903394685     PISSN: 15228517     EISSN: 15235866     Source Type: Journal    
DOI: 10.1093/neuonc/nou047     Document Type: Article

References (26)

1. Louis DN, Ohgaki H, Wiestler OD, et al. The 2007 WHO classification of tumours of the central nervous system. Acta Neuropathol. 2007;114(2):97-109. (Pubitemid 47103521)
2. Giannini C, Burger PC, Berkey BA, et al. Anaplastic oligodendroglial tumors: refining the correlation among histopathology, 1p 19q deletion and clinical outcome in Intergroup Radiation Therapy Oncology Group Trial 9402. Brain Pathol. 2008;18(3):360-369. (Pubitemid 351782844)
3. Giannini C, Scheithauer BW, Weaver AL, et al. Oligodendrogliomas: reproducibility and prognostic value of histologic diagnosis and grading. J Neuropathol Exp Neurol. 2001;60(3):248-262. (Pubitemid 32209644)
4. Miller CR, Dunham CP, Scheithauer BW, et al. Significance of necrosis in grading of oligodendroglial neoplasms: a clinicopathologic and genetic study of newly diagnosed high-grade gliomas. J Clin Oncol. 2006;24(34):5419-5426. (Pubitemid 46623175)
5. Griffin CA, Burger P, Morsberger L, et al. Identification of der(1;19) (q10;p10) in five oligodendrogliomas suggests mechanism of concurrent 1p and 19q loss. J Neuropathol Exp Neurol. 2006;65(10):988-994. (Pubitemid 44521799)
6. Jenkins RB, Blair H, Ballman KV, et al. A t(1;19)(q10;p10) mediates the combined deletions of 1p and 19q and predicts a better prognosis of patients with oligodendroglioma. Cancer Res. 2006;66(20):9852-9861. (Pubitemid 44672036)
7. Labussiere M, Idbaih A, Wang XW, et al. All the 1p19q codeleted gliomas are mutated on IDH1 or IDH2. Neurology. 2010;74(23):1886-1890.
8. Yan H, Parsons DW, Jin G, et al. IDH1 and IDH2 mutations in gliomas. N Engl J Med. 2009;360(8):765-773.
9. Stupp R, Mason WP, van den Bent MJ, et al. Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. N Engl J Med. 2005;352(10):987-996. (Pubitemid 40349501)
10. Cairncross G, Wang M, Shaw E, et al. Phase III trial of chemoradiotherapy for anaplastic oligodendroglioma: long-term results of RTOG 9402. J Clin Oncol. 2013;31(3):337-343.
11. van den Bent MJ, Brandes AA, Taphoorn MJ, et al. Adjuvant procarbazine, lomustine, and vincristine chemotherapy in newly diagnosed anaplastic oligodendroglioma: long-term follow-up of EORTC brain tumor group study 26951. J Clin Oncol. 2013;31(3):344-350.
12. Mokhtari K, Ducray F, Kros JM, et al. Alpha-internexin expression predicts outcome in anaplastic oligodendroglial tumors and may positively impact the efficacy of chemotherapy: European organization for research and treatment of cancer trial 26951. Cancer. 2011;117(13):3014-3026.
13. Coulibaly B, Nanni I, Quilichini B, et al. Epidermal growth factor receptor in glioblastomas: correlation between gene copy number and protein expression. Hum Pathol. 2010;41(6):815-823.
14. Idbaih A, Ducray F, Dehais C, et al. SNP array analysis reveals novel genomic abnormalities including copy neutral loss of heterozygosity in anaplastic oligodendrogliomas. PLoS One. 2012;7(10):e45950.
15. Craig JM, Vena N, Ramkissoon S, et al. DNA fragmentation simulation method (FSM) and fragment size matching improve aCGH performance of FFPE tissues. PLoS One. 2012;7(6):e38881.
16. Kaloshi G, Benouaich-Amiel A, Diakite F, et al. Temozolomide for low-grade gliomas: predictive impact of 1p/19q loss on response and outcome. Neurology. 2007;68(21):1831-1836. (Pubitemid 46791397)
17. Houillier C, Wang X, Kaloshi G, et al. IDH1 or IDH2 mutations predict longer survival and response to temozolomide in low-grade gliomas. Neurology. 2010;75(17):1560-1566.
18. Mueller W, Hartmann C, Hoffmann A, et al. Genetic signature of oligoastrocytomas correlates with tumor location and denotes distinct molecular subsets. Am J Pathol. 2002;161(1):313-319. (Pubitemid 34760797)
19. McDonald JM, See SJ, Tremont IW, et al. The prognostic impact of histology and 1p/19q status in anaplastic oligodendroglial tumors. Cancer. 2005;104(7):1468-1477. (Pubitemid 41356162)
20. Verhaak RG, Hoadley KA, Purdom E, et al. Integrated genomic analysis identifies clinically relevant subtypes of glioblastoma characterized by abnormalities in PDGFRA, IDH1, EGFR, and NF1. Cancer Cell. 2010;17(1):98-110.
21. Perry A, Aldape KD, George DH, et al. Small cell astrocytoma: an aggressive variant that is clinicopathologically and genetically distinct from anaplastic oligodendroglioma. Cancer. 2004;101(10):2318-2326. (Pubitemid 39458690)
22. Jenkinson MD, du Plessis DG, Smith TS, et al. Histological growth patterns and genotype in oligodendroglial tumours: correlation with MRI features. Brain. 2006;129(7):1884-1891. (Pubitemid 43999419)
23. Kim JW, Park CK, Park SH, et al. Relationship between radiological characteristics and combined 1p and 19q deletion in World Health Organization grade III oligodendroglial tumours. J Neurol Neurosurg Psychiatry. 2011;82(2):224-227.
24. Bigner SH, Rasheed BK, Wiltshire R, et al. Morphologic and molecular genetic aspects of oligodendroglial neoplasms. Neuro Oncol. 1999;1(1):52-60.
25. Godfraind C, Rousseau E, Ruchoux MM, et al. Tumour necrosis and microvascular proliferation are associated with 9p deletion and CDKN2A alterations in 1p/19q-deleted oligodendrogliomas. Neuropathol Appl Neurobiol. 2003;29(5):462-471. (Pubitemid 37222720)
26. Reyes-Botero G, Dehais C, Idbaih A, et al. Contrast enhancement in 1p/19q co-deleted anaplastic oligodendrogliomas is associated with 9p loss, genomic instability and angiogenic gene expression. Neuro Oncol. 2014;16(5):662-670.